MACKENZIE COLEMAN: Open Payments
NPI 1790406270 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 45 payments from 12 companies in 2025. Trend: 2023 $255 · 2024 $1,114 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $348 |
| PFIZER INC. | 8 | $152 |
| ABBVIE INC. | 4 | $107 |
| Lilly USA, LLC | 5 | $94 |
| Novo Nordisk Inc | 5 | $91 |
| Amgen Inc. | 3 | $52 |
| Exact Sciences Corporation | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: BREZTRI, AIRSUPRA, MOUNJARO, NURTEC ODT, FARXIGA, UBRELVY, Ozempic, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
